We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
I mean it's still the results are pretty dismal I mean usually they they get a couple years but two years on two and a half years on they come back and they've got another lump that lump and exilic isn't the tumor in the in the chest so it's the chemotherapy almost assuredly isn't helping is it no I really don't think is doing much so it's really frustrating
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so usually they come with a palpable mess and they already have nose and exilla so so you in that situation you still do modified radical mastectomies we do we used do a modified radical mastectomy and then follow with adriam pyos myo and do that sort of every month for about six cycles and I mean it's still the results are are pretty dismal I mean usually they they get a couple years but two years on two and a half years on they come back and they've got another lump they got lump in the axilla there's another tumor in the in the chest
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.